Overview
- ARK Invest purchased 171,176 shares of Tempus AI for approximately $8.54 million, emphasizing confidence in AI-driven healthcare innovation.
- The firm acquired 46,205 shares of GitLab for $2.4 million, reflecting support for AI-integrated DevOps solutions in software development.
- ARK sold 12,595 Meta Platforms shares valued at $7.62 million, citing challenges with privacy concerns and global expansion efforts.
- Over 509,799 shares of UiPath were sold for $5.49 million, signaling a pivot away from automation-focused investments.
- Meta Platforms announced plans to allocate $65 billion toward AI development in 2025, but ARK's reduced exposure suggests skepticism about near-term returns.